Results 181 to 190 of about 31,123,995 (208)

Japanese intractable and rare dermatologic diseases: From the official skin-centered nanbyo core to an illustrative mechanism-based framework. [PDF]

Intractable Rare Dis Res
Han Y, Qin TG, Song P.
europepmc   +1 more source

<i>TSC2</i> GAP Domain V1646Cfs*7 Variant Alters Protein Stability and Interaction Networks in Tuberous Sclerosis Complex. [PDF]

Neurol Genet
Utami KH, Han VX, Mohammad Yusof NAB, Ramaswamy Y, Feng J, Tay SKH, Langley SR, Pouladi MA.   +7 more
europepmc   +1 more source

Sirolimus excretion in breast milk: a preliminary investigation. [PDF]

Front Pharmacol
Nogueira E, Bento da Silva A, Rebelo M, Lopes JA, Bronze MDR, Duarte N.   +5 more
europepmc   +1 more source

Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference [PDF]

Pediatric Neurology, 2013
BackgroundTuberous sclerosis complex is highly variable in clinical presentation and findings. Disease manifestations continue to develop over the lifetime of an affected individual.
Harry Chugani, Michael Frost, David Neal Franz   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

A Role of the Mammalian Target of Rapamycin (mTOR) in Glutamate-Induced Down-regulation of Tuberous Sclerosis Complex Proteins 2 (TSC2)

Journal of Molecular Neuroscience, 2012
Mammalian target of rapamycin (mTOR) signaling plays a critical role in the regulation of activity-dependent protein synthesis in neurons. It is well established that the GTPase-activating protein tuberous sclerosis complex proteins (2TSC2) is an upstream inhibitor of mTOR.
Wenjuan, Ru, Yanxi, Peng, Ling, Zhong, Shao-Jun, Tang   +3 more
openaire   +2 more sources

The serine protease HtrA1 specifically interacts and degrades the Tuberous Sclerosis Complex 2 protein (TSC2).

2010
Hamartin and tuberin are products of the tumor suppressor genes TSC1 and TSC2, respectively. Mutations affecting either gene result in the tuberous sclerosis syndrome, a neurologic genetic disorder characterized by the formation of multiple benign tumors or hamartomas. In this study, we report the identification of TSC2, but not TSC1, as a substrate of
Campioni M, Severino A, Manente L, Tuduce IL, Toldo S, Caraglia M, Crispi S, Ehrmann M, De Falco M, de Luca A, He X, Maguire J, Shridhar V, Baldi A   +13 more
openaire   +2 more sources

Architecture of the Tuberous Sclerosis Protein Complex

Journal of Molecular Biology, 2021
Kailash Ramlaul, Natàlia de Martín Garrido, Christopher Hs Aylett   +2 more
exaly  

Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations

Pediatric Neurology, 2021
Harry Chugani, Michael Frost, David Neal Franz   +2 more
exaly  

Faculty Opinions recommendation of Tuberous sclerosis complex 2 gene product interacts with human SMAD proteins. A molecular link of two tumor suppressor pathways.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature, 2004
openaire   +1 more source